Magnesium and Vraylar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Magnesium (magnesium) and Vraylar (cariprazine hydrochloride). Common drug interactions include upper respiratory tract infection among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Magnesium and Vraylar. It is created by eHealthMe based on reports of 80 people who take the same drugs from the FDA, and is updated regularly.

What is Magnesium?

Magnesium has active ingredients of magnesium. It is often used in constipation. eHealthMe is studying from 121,144 Magnesium users. Check the latest studies of Magnesium.

What is Vraylar?

Vraylar has active ingredients of cariprazine hydrochloride. eHealthMe is studying from 6,136 Vraylar users. Check the latest studies of Vraylar.

On Jul, 13, 2026

80 people who take Magnesium and Vraylar together, and have interactions are studied.

Magnesium and Vraylar drug interactions.

What are the common drug interactions of Magnesium and Vraylar, by gender? *:

female:

Upper respiratory tract infection
Attention deficit hyperactivity disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Fall
Headache (pain in head)
Skin infection
Cataplexy (loss of muscle tone accompanied by full conscious awareness)
Dyskinesia (abnormality or impairment of voluntary movement)
Asthenia (weakness)
Erythema (redness of the skin)

male:

Fatigue (feeling of tiredness)
Drug ineffective
Heart rate increased
Periodic limb movement disorder
Somnolence (a state of near-sleep, a strong desire for sleep)
Suicidal ideation
Anxiety
Blood prolactin increased
Blood testosterone decreased
Decreased interest

What are the common drug interactions of Magnesium and Vraylar, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Fatigue (feeling of tiredness)
Akathisia (a movement disorder characterized by a feeling of inner restlessness)
Dyskinesia (abnormality or impairment of voluntary movement)
Chest pain
Bradykinesia (decreased bodily movement. it is associated with basal ganglia diseases)
Hypokinesia (decreased bodily movement)
Tardive dyskinesia (a disorder that involves involuntary movements)
Blood prolactin increased
Blood testosterone decreased
Cataplexy (loss of muscle tone accompanied by full conscious awareness)

30-39:

Tardive dyskinesia (a disorder that involves involuntary movements)
Headache (pain in head)
Nausea (feeling of having an urge to vomit)
Adrenal disorder
Adverse reaction
Chills (felling of cold)
Confusional state
Cough
Depression
Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)

40-49:

Confusional state
Disturbance in attention
Essential hypertension (primary hypertension)
Headache (pain in head)
Hordeolum (small collection of pus (abscess) on the eyelid)
Hypercalcaemia (elevated calcium (ca+) level in the blood)
Hyperhidrosis (abnormally increased sweating)
Hypermetabolism (abnormal increase in the body's basal metabolic rate)
Injection site erythema (redness at injection site)
Injection site pruritus (severe itching at injection site)

50-59:

Gait disturbance
Joint swelling
Pneumonia
Weight increased
Alcoholism (problems with alcohol)
Arthropathy
Head injury
Injection site mass
Injection site pain
Injection site reaction

60+:

Fall
Asthenia (weakness)
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Fatigue (feeling of tiredness)
Localised infection (infection at the single location)
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
Oedema peripheral (superficial swelling)
Osteomyelitis (infection of bone)
Rash erythematous (redness of the skin)
Sleep disorder

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 19 people, 23.75%
Bipolar Disorder (mood disorder): 9 people, 11.25%
Pain: 8 people, 10.00%
Insomnia (sleeplessness): 7 people, 8.75%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 7 people, 8.75%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 7.50%
Depression: 6 people, 7.50%
Stress And Anxiety: 5 people, 6.25%
Immunodeficiency Common Variable: 5 people, 6.25%
Bipolar I Disorder (mood disorder that is characterized by at least one manic or mixed episode): 5 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Magnesium and Vraylar?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously